Medtech sectors views US tariff hike as barrier to growth
US President Donald Trump announced tariffs on April 2, 2025 as part of his “Liberation Day” economic plan. The tariffs include a 26 per cent reciprocal duty on Indian imports. The Trump administration exempted pharmaceutical exports from the tariff, but medical devices were not included in the package. Source:- Express Healthcare
